January 23, 2018 / 1:40 PM / a year ago

BRIEF-Cardiome Announces Expanded Label For Aggrastat In China

Jan 23 (Reuters) - Cardiome Pharma Corp:

* CARDIOME ANNOUNCES EXPANDED LABEL FOR AGGRASTAT® IN CHINA INCLUDING NEW STEMI INDICATION AND HIGH DOSE BOLUS REGIMEN

* CARDIOME PHARMA - AGGRASTAT EXPANDED LABEL NOW INCLUDE PATIENTS WITH STEMI WHO ARE INTENDED FOR PRIMARY PERCUTANEOUS CORONARY INTERVENTION

* CARDIOME PHARMA - CHINESE CENTER FOR DRUG EVALUATION ALSO APPROVED AGGRASTAT HIGH DOSE BOLUS REGIMEN TO BE USED ON BOTH INDICATED PATIENT POPULATIONS IN STUDY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below